Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 3119
Gene Symbol: HLA-DQB1
HLA-DQB1 		0.300 Biomarker group CTD_human Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer. 27749845 2016
Entrez Id: 3123
Gene Symbol: HLA-DRB1
HLA-DRB1 		0.300 Biomarker group CTD_human Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer. 27749845 2016
Entrez Id: 3117
Gene Symbol: HLA-DQA1
HLA-DQA1 		0.300 Biomarker group CTD_human Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer. 27749845 2016
Entrez Id: 10397
Gene Symbol: NDRG1
NDRG1 		0.300 Biomarker group CTD_human Prognostic significance of NDRG1 expression in oral and oropharyngeal squamous cell carcinoma. 22972152 2012
Entrez Id: 673
Gene Symbol: BRAF
BRAF 		0.010 GeneticVariation group BEFREE Molecular defects in BRAF wild-type ameloblastomas and craniopharyngiomas-differences in mutation profiles in epithelial-derived oropharyngeal neoplasms. 29546640 2018
Entrez Id: 115482713
Gene Symbol: H3P10
H3P10 		0.010 Biomarker group BEFREE The presence of HPV and p16 in MCN was correlated with oropharyngeal tumor location and prognosis. 22728322 2012
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A 		0.010 Biomarker group BEFREE The presence of HPV and p16 in MCN was correlated with oropharyngeal tumor location and prognosis. 22728322 2012
Entrez Id: 4233
Gene Symbol: MET
MET 		0.010 GeneticVariation group LHGDN Prevalence and clinical impact of Met Y1253D-activating point mutation in radiotherapy-treated squamous cell cancer of the oropharynx. 14627992 2003